Document is current

Any future updates will be listed below

Breakthrough Therapy, PRIME and Sakigake: A Comparison Between Neuroscience and Oncology in Obtaining Preferred Regulatory Status

Crossref DOI link: https://doi.org/10.1007/s43441-019-00100-7

Published Online: 2020-01-06

Published Print: 2020-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark